Background. A family history (FH) of alcohol dependence (AD) not only increases the risk for AD, but is also associated with an increased risk for mood and anxiety disorders. However, it is unknown how a FH of AD affects neural substrates in patients with mood and anxiety disorders. In this study we examined the effects of an alcoholic FH on cognitive and emotional functions in these patients using functional Magnetic Resonance Imaging (fMRI).
INTRODUCTION
S tudies on familial alcohol dependence have typically focused on the risk for, and manifestation of, alcohol dependence (AD) in individuals. These studies show that a positive family history of AD (FH+) is associated with a higher risk for alcohol use disorders (Hasin et al. 1997; Nurnberger et al. 2004) , and, once developed, with a recurrent course and more impairments (Araujo and Monteiro 1995; Milne et al. 2009; Penick et al. 1987) , remaining even after abstinence (Moriyama et al. 2006) . In both AD patients and non-alcoholic individuals, a FH of AD may also contribute to a higher probability of psychiatric disorders other than AD (Araujo and Monteiro 1995; Dawson and Grant 1998; Knappe et al. 2009; Nurnberger et al. 2004; Schuckit et al. 1995; Sjoerds et al. 2012b) , such as mood and/or anxiety disorders. This implies a role of familial AD in the development of mood/anxiety disorders. However, little is known about the influence of familial AD on the neurophysiology of manifested mood and anxiety disorders.
Cognitive impairments often seen in alcoholic as well as non-alcoholic individuals with a FH of AD are disinhibition and poor behavioral control (Peterson et al. 1992; Poon et al. 2000) . Brain areas involved in these cognitive control functions, including dorsal prefrontal areas and the cingulate gyrus, show abnormal activity in FH+ individuals during various neuropsychological tasks (Schweinsburg et al. 2004; Silveri et al. 2011; Spadoni et al. 2008) and decreased functional connectivity with other brain regions (Wetherill et al. 2011) . Notably, these areas are also implicated in neurobiological models of emotion processing as part of a dorsal system, involved in top-down control and regulation of affective states and subsequent behaviors (Drevets et al. 2008; Phillips et al. 2003a) . Additionally, some studies have shown that the presence of familial AD is associated with abnormal emotion processing (Acheson et al. 2009; Bjork et al. 2008; Glahn et al. 2007; Hill et al. 2007a) .
Para-limbic areas such as the insula, amygdala, and ventral prefrontal cortex, which are involved in emotional appraisal and identification of emotional significance of a stimulus (Phillips et al. 2003a) , show structural and functional abnormalities in FH+ individuals (Bjork et al. 2008; Heitzeg et al. 2008; Hill et al. 2001; Hill et al. 2009 ). Importantly, impairments in these areas are also associated with the development of mood problems and negative affect (Tessner and Hill 2010) . Together with decreased cognitive control functions these limbic abnormalities may underlie an unfavorable symptom profile in patients with mood/anxiety disorders who have a FH of AD compared with those without such a FH (FH-).
Recently, evidence for an effect of a FH of AD on the neural substrate of mood/anxiety disorders was provided, i.e. depressed patients with a FH of AD demonstrated a significantly better anti-depressant response to the N-methyl-D-aspartate (NMDA)-receptor antagonist ketamine than patients without a FH of AD (Phelps et al. 2009 ). These findings indicate that depressed (and probably also anxious) patients may have a different neurobiological profile depending on the presence of a FH of AD, including differences in neurotransmitter and receptor profile, potentially leading to divergent performance during cognitive or emotional tasks. This experimental evidence suggests heterogeneity between depression/anxiety patients based on the presence or absence of a FH of AD and is consistent with the high variability in imaging findings in these populations (Fitzgerald et al. 2008) , especially concerning cognitive functions. Therefore, it is desirable to further study the influence of familial AD on the neurophysiological profile in patients with mood/anxiety disorders to clarify the pathway through which a FH of AD predisposes to the development of mood-and anxiety disorders.
The current study is the first to examine whether a FH of AD influences the functional neurobiology of mood/anxiety disorders, and whether this influence operates through pathways involved in cognitive or emotion processing, or both. In a sample of non-alcoholic adult patients with mood/anxiety disorders, functional magnetic resonance imaging (fMRI) was used to investigate regional brain activity during a planning task and an emotional appraisal task. We compared patients with and without a first-degree FH of AD. We hypothesized that the presence of a FH of AD affects cognitive control functions and modulates responsiveness to emotional stimuli, indicated by differences between the FH-and FH+ groups in performance levels and activation in brain areas associated with these functions. To facilitate the interpretation of our findings, differences in performance levels and brain activation between the FH-and the FH+ group were post-hoc compared with those of healthy controls (HC) without a FH of AD.
METHODS

Sample
Participants were drawn from the observational multi-center Netherlands Study of Depression and Anxiety (NESDA). Within NESDA (N = 2981), a large neuroimaging study was embedded (N = 301), where 233 outpatients with a current (< 6 months) Diagnostic and Statistical Manual of Mental Disorders, fourth edition, text revision (DSM-IV-TR) diagnosis of major depressive disorder (MDD) and/or anxiety disorder (panic disorder, social anxiety disorder, generalized anxiety disorder), and 68 HCs without any lifetime DSM-IV-TR diagnosis were studied using functional magnetic resonance imaging (fMRI). Detailed descriptions of the NESDA study design and the NESDA-Neuroimaging study have been published elsewhere (Penninx et al. 2008; van Tol et al. 2010) . Inclusion and exclusion criteria of the NESDA-Neuroimaging sample are described in the supplementary material (text S3.1). For this report, we selected participants with a current diagnosis of MDD and/or anxiety disorder based on the Composite International Diagnostic Interview (Robins et al. 1988 ) who reported to have (a) at least one first-degree relative (parents/siblings) with a history of AD (FH+) or (b) no relatives at all with a history of AD or other substance use disorder (FH-). We excluded (a) participants with imaging data of poor quality; (b) participants who lacked data on either of the two task paradigms, or who showed poor task involvement by having less than an overall performance of 75% for the planning task and/or over 40 missing responses for the emotional appraisal task; and c) participants who had a current (< 1 year) and/or lifetime (>1 year) diagnosis of alcohol abuse or dependence. Of the 233 patients, 77 met criteria for the FH-group and 31 for the FH+ group. Of the 68 HCs, 31 served as comparison group without a FH of AD. More information on inclusion/exclusion steps can be found in the flowchart in supplementary figure S3.3.
The research protocol was approved by the medical ethical review board of the participating universities and all participants provided written informed consent.
Clinical assessment
Family history was obtained using the family-tree method (Fyer and Weissman 1999) , an interview assessing the presence of psychiatric disorders, including AD, among relatives of the participant with acceptable inter-rater reliability (Andreasen et al. 1977) . The Alcohol Use Disorder Identification Test (AUDIT) (Babor et al. 1989) for alcohol use and dependence, and the Fagerström questionnaire (Heatherton et al. 1991) for the assessment of smoking behavior and nicotine dependence were used to provide a more detailed description of alcohol and nicotine use and related problems. On the scanning day, depression severity and mood state were assessed using Dutch versions of the Inventory of Depressive Symptomatology (IDS) (Rush et al. 1996) and the Montgomery-Åsberg Depression Rating Scale (MADRS) (Montgomery and Asberg 1979), whereas anxiety severity was measured with the Beck Anxiety Inventory (BAI) (Beck et al. 1988 ).
Task paradigms
To assess executive functions, we used a parametric visuospatial planning task (Tower of London; ToL) (van den Heuvel et al. 2003) . This task involves recruitment of the dorsolateral prefrontal cortex (DLPFC) and anterior cingulate cortex (ACC), brain areas involved in cognitive control/planning and regulation of emotion processing (Phillips et al. 2003a) . The ToL task has previously been associated with functional impairments in FH+ compared with FH-individuals (Dolan et al. 2008 ). An emotional word memory task (EWM) (Daselaar et al. 2003 ) was used to study emotional responsiveness during encoding of mood-congruent (negative), mood-incongruent (positive) and neutral words. The EWM-task has been associated with activation of (para)limbic structures involved in primary appraisal of emotional significance (Phillips et al. 2003a) . A detailed description of the two tasks can be found in the supplementary material.
Briefly, during the ToL-task, participants were shown a starting configuration of beads and were asked to compute the minimal number of steps (ranging from 1 to 5) to reach a target configuration (supplementary figure S3 .4). The EWM-task consisted of an encoding phase, during which participants had to indicate whether the shown words had a positive, neutral or negative valence, and a recognition phase in which participants had to indicate whether they had seen the words during the encoding phase among novel distracter words (supplementary figure S3.5). For the current analysis we focused on performance and brain activity during words that were successfully encoded (hence, subsequently remembered during the recognition phase) in each condition (positive/negative/neutral). During baseline trials, participants were requested to perform button presses as indicated ('<<left', '<<middle>>', 'right>>').
Image acquisition & processing
Imaging data were acquired using Philips 3-Tesla MR-systems (Best, The Netherlands) located at the Academic Medical Center Amsterdam (AMC), the Leiden University Medical Center (LUMC), and the University Medical Center Groningen (UMCG). A SENSE-8 (UMCG, LUMC) and a SENSE-6 (AMC) channel head coil were used for radio frequency transmission and reception. For each subject, echo-planar images were obtained using a T2*-weighted gradient echo sequence [repetition time (TR) = 2300 ms; echo time (TE) = 30 ms (UMCG: 28 ms), matrix size: 96 x 96 (UMCG: 64 x 64), 35 axial slices (UMCG: 39), interleaved acquisition, 2.29 x 2.29 mm in-plane resolution (UMCG: 3 x 3 mm), 3 mm slice thickness]. Anatomical imaging was performed between the encoding and recognition phases of the EWM task, and included a sagittal three-dimensional gradient-echo T1-weighted sequence [TR = 9 ms, TE = 3.5 ms; matrix 256 x 256; voxel size: 1 x 1 x 1 mm; 170 slices] for co-registration with the functional data.
Images were preprocessed with SPM5 [Wellcome Trust Centre for Neuroimaging, London (http://www.fil.ion.ucl.ac.uk/spm/software/)] implemented in Matlab 7.3.0 (The Mathworks Inc., Natick, MA, USA). Before pre-processing, images were manually reoriented to the anterior commissure. Temporal and spatial preprocessing of the data included slicetime correction, image realignment, co-registration between the anatomical and mean-EPI images, warping to the standard Montreal Neurological Institute (MNI) space as defined by the SPM5 T1 template, re-sampling into a 3 x 3 x 3 mm grid, and spatial smoothing using a Gaussian kernel (8 mm full-width at half-maximum). Data of participants with movement greater than 3 mm in more than one direction were excluded. To remove low-frequency temporal noise, a high-pass filter was applied, with a cut-off of 128 s, to the fMRI time-series.
Statistical analyses
Sample characteristics and task performance Sample characteristics and performance data were analyzed using SPSS (Chicago, IL, USA). Normally distributed characteristics and clinical data were analyzed using independent-samples t tests. If data did not meet assumptions required for parametric analysis, log transformations were made; if following log transformation a variable was still not normally distributed, the non-parametric Mann-Whitney U test for two independent samples was used. Categorical data were analyzed using χ 2 tests. Performance data on both fMRI tasks (accuracy and response times) were examined by means of a repeated-measures analysis of covariance. Dependent factors for the ToL task were the proportion correct scores and mean response times per trial type (1-5 steps). For the EWM task the dependent factors were the proportion of subsequently remembered words and mean response time during successful encoding per valence category (positive/negative/neutral). For both tasks the between-subject factor was group (FH-/ FH+), whereas age, education and current diagnosis (MDD only, anxiety only, or comorbid MDD/anxiety) were added as covariates. Significance was set at P < .05.
Imaging data
Analysis of imaging data was performed in the context of the general linear model (Friston et al. 1995) in SPM8. Onsets of each stimulus type were modeled with a delta function convolved with a synthetic hemodynamic response function and modulated using response times. For the ToLtask, contrast images containing parameter estimates for task load (steps 1-5) were calculated per participant on a voxel-by-voxel basis. These were entered into second-level analyses for group comparisons using a whole-brain two sample t-test. For the EWM-task, successfully encoded items (i.e. items during the encoding phase that were correctly recognized during the retrieval phase) were contrasted with baseline items at first level, and entered in a 2 (group: FH-/ FH+) x 3 (valence: positive / negative / neutral) full factorial second-level model to test for main effect of task. Group interactions were assessed per valence in three separate two-sample t tests All analyses were performed with age and scanning location as covariates, in line with previous imaging studies on the ToL and EWM within the NESDA cohort (van Tol et al. 2011; van Tol et al. 2012) . To capitalize on our sample size we included participants using selective serotonin reuptake inhibitor (SSRI) medication, since previous findings from our group demonstrated that SSRI use did not affect imaging results of these tasks (van Tol et al. 2011; van Tol et al. 2012 ). However, we performed post-hoc analyses with SSRI-use as an additional covariate. In order to study possible effects of state-dependent severity of depression and anxiety, we additionally added BAI and IDS scores as covariates to the main analyses.
Main effects over groups are reported in supplementary table S3.7 at a threshold of P < .001 uncorrected (P uncorr. ). To restrict the search for interaction effects to voxels which were identified in the main task effects, t test group comparisons were masked with the orthogonal main task effect over all groups at P uncorr. < .001. Group x task interaction effects were visually inspected at a threshold of P uncorr. < .001 and clustersize > 3 voxels for effects in a priori regions of interest (ROIs) as defined by the Automated Anatomical Labeling atlas (Maldjian et al. 2003) , implemented in the WFU Pickatlas toolbox (Wake Forest University School of Medicine). For the ToL task the ROIs comprised the DLPFC and ACC. For the EWM the ROIs were defined as the hippocampus, amygda-la, insula, inferior frontal gyrus and medial prefrontal gyrus. Following previous findings of smaller gray matter volumes in patients with an alcoholic FH in non-alcoholic adults (Sjoerds et al. 2012) , we additionally designated the (right) parahippocampal gyrus as an area of interest for both fMRI tasks, applying the small volume correction implemented in SPM with a sphere twice the size of the smoothing kernel centered over the peak coordinates of the previously reported finding (MNI: x = 20, y = -37, z = -11).
Post-hoc comparison to Healthy Controls
In order to test and interpret how effects of FH in patients with mood/anxiety disorders are related to normal regional brain function, we post-hoc compared the observed differences between the FH+ and FH-groups with findings from a group of HCs without a FH of AD. We therefore added the HC group as a third group to post-hoc analyses of variance (ANOVA) for the parametric contrast of the ToL task and per valence for the EWM task. Comparable secondary analyses were done for the comparison of baseline characteristics and performance data, adding HC as a third group in the repeated-measures ANOVAs.
RESULTS
Sample characteristics FH+ and FH-
Sample characteristics are listed in table 3.1. The two patient groups did not differ significantly (P > .05) on sociodemographic variables, SSRI use, depression and anxiety scores, alcohol use and smoking. Distribution of current MDD only, current anxiety only and co-morbid MDD and anxiety was the same for both groups, as well as age of onset for the affective disorders. The groups only differed on the presence of alcoholic FH, and not on the presence of familial depression/anxiety.
Performance and fMRI results FH+ and FH-
Tower of London Task
Performance data Overall, no effect of FH of AD was observed on planning accuracy (F 2.4;246.99 = .46; P = .67). However, a significant main group effect on response times was found (F 1;103 = 6.73; P = .01), and the group x task load interaction was significant due to slower responding by the FH+ group during the more difficult trials (4 and 5 steps; figure 3.1) (F 1.59;163.45 = 3.62; P = .04).
Imaging data FH+ patients showed significantly more activation in right superior (Brodmann's Area (BA) 6; Z = 3.21) and right middle (BA 46; Z = 3.54) frontal gyrus, compared with FH-participants ( figure. 3.2a) . At a slightly more liberal threshold (P uncorr. < .005), the anterior cingulate cortex (BA 24; Z = 2.81) showed increased activation in FH+, an area of a priori interest. Results were unaffected when variations of depression / anxiety severity and SSRI use were taken into account. No significant clusters were visible in the FH-> FH+ contrast, even at a threshold of P < .005 whole-brain uncorrected. The main task effect is displayed in supplementary table S3.7.
Emotional Word Memory Task
Performance data The two groups did not differ in classification behavior (F 1.17, 114 .71 = 0.046; P = .96) (see supplemen- .332
How often do you take an alcoholic drink?* M(SD) Imaging data During positive word encoding the FH+ group activated the right insula (BA 13; Z = 4.22) significantly more than the FH-group ( figure 3.2b) . The opposite contrast, testing for increased brain activity in FH-compared with FH+, did not show significant results. Activation during negative and neutral word encoding did not reveal group differences. Adding SSRI use and depression / anxiety severity to the main analysis did not influence the results. Main task effects are displayed in supplementary table S3.7. 
Comparison with HCs
For comparisons on sample characteristics between the HC group and the two patient groups see table 3.1. The HC group was significantly older and higher educated than the two patient groups (FH-and FH+). HCs scored, as expected, lower on depression and anxiety symptom severity questionnaires. Additionally, the HC group contained relatively few participants with a FH of depression / anxiety. The two patient groups did not differ from HCs in performance accuracy for both tasks. However, HCs showed trendwise shorter response times compared with the FH+ group on the ToL task (F 3.861, 38.989 = 2.003; P = .094; figure 3.1).
During the ToL task, brain activation in the superior and middle frontal gyrus (FH+ > FH-) in the FH+ group was significantly higher compared with the HC group, an effect that was particularly robust in the middle frontal gyrus. During the EWM-task, activation in the right insula in the FH+ group was comparable with that of HCs during positive word encoding. Plots of the three groups in the described areas are shown in figure 3.2 (right panels).
DISCUSSION
In the present study, we investigated the effects of a FH of AD on neural correlates of cognitive functions and emotional perception in patients with mood / anxiety disorders. Although extensive studies are available on the association between FH of AD and manifestation of AD, the current study suggests that a FH of AD also affects the underlying neurophysiology of patients with mood / anxiety disorders. To our knowledge, this is the first study examining the neurophysiological correlates of a FH of AD in patients with mood / anxiety disorders. Results indicate that the presence of a FH of AD has a negative influence on cognitive functions during a visuospatial planning task and a normalizing effect during positive word encoding in these patients. These results could not be explained by differences in depression-and anxiety severity or medication use and therefore confirm our hypothesis that a FH of AD independently affects cognitive functions and modulates emotion processing in patients with mood / anxiety disorders.
In patients with a FH of AD, increased response times and greater regional dorsolateral and trendwise dorsomedial brain activity during planning coupled with equal performance accuracy suggests the need to recruit additional resources to attain the same level of accuracy (i.e. reduced neuronal efficiency), as compared with patients without such a history and HCs. Reduced neuronal efficiency of frontal areas during cognitively challenging tasks was reported earlier in FH+ youth (Silveri et al. 2011) , heavy cannabis users (Kanayama et al. 2004) , and after sleep deprivation (Drummond et al. 2001; Drummond et al. 2005) . As the DLPFC and ACC are part of a network involved in top-down emotional regulation (Drevets et al. 2008; Phillips et al. 2003a) , impairments in these regions could lead to a decreased capacity for emotion regulation, further contributing to an unfavorable course of mood / anxiety disorders.
During positive word encoding we observed that a family history of AD was associated with increased recruitment of the right posterior insula compared with FH-, in the absence of behavioral differences. This activation in FH+ patients, however, was comparable with that in the HC group, indicating that a hypoactivation, as was seen in FH-patients, was absent in the presence of a FH of AD. Hypoactivation during positive word encoding was recently reported in the hippocampus in depressed and anxious patients, independent of illness severity (van Tol et al. 2012 ). We did not find FH group differences in the hippocampus, but rather in the more posterior part of the right insula, which is, in connection with the anterior insula, involved in bottom-up detection of and autonomic reactivity towards salient stimuli (Craig 2003; Menon and Uddin 2010) . Hypoactivation in the insula (as seen in FH-) may be related to a blunted response to positive stimuli, which would be in concordance with the mood-incongruence bias hypothesis. Mood-incongruent bias, i.e. attentional and memory bias away from positive information (Burt et al. 1995; van Tol et al. 2012; van Wingen et al. 2010 ) is associated with the decreased ability to enjoy positive situations, possibly reflective of anhedonia (Bower 1981) . On the other hand, mood-congruent bias, i.e. attentional and memory bias towards negative information (Bradley et al. 1996; Elliott et al. 2002; Phillips et al. 2003b) contributes to the development and persistence of negative affective symptoms (Elliott et al. 2002) . We did not observe a decreased insula response to positive stimuli in FH+, suggesting a different pathway through which depression and anxiety symptoms are maintained in patients with depressive / anxiety disorders with a FH of AD, for example through decreased cognitive functions, as shown above with respect to the ToL task, contributing to a decreased ability to regulate negative affect. These differences in the neurophysiology of depressed / anxious patients with and without a FH of AD could also be related to differences in receptor profiles, as suggested by treatment studies (Phelps et al. 2009 ).
The current analyses were controlled for severity of current depression / anxiety and the observed results therefore cannot be attributed to differences in state depression / anxiety between the FH+ and FH-groups. This implies that the observed effects of a FH of AD may have been present prior to the onset of the depression / anxiety either through environmental, genetic or epigenetic pathways. Including a fourth group of HCs with a positive FH of AD could have allowed us to further address this issue; however within the NESDA-Neuroimaging sample this subgroup was too small (N = 6) for meaningful analyses. Notably, a previous fMRI study from the NESDA-Neuroimaging sample (van Tol et al. 2011) found that patients with more severe depression showed increased prefrontal activation during visuospatial planning, a similar BOLD-effect as found within our FH+ group. Comparing these results to ours thus suggests that patients with depression / anxiety constitute a heterogeneous group, which can partly be explained by the presence or absence of family histories such as AD. However, direct comparisons between these two studies are not straightforward, because in the present study we focused on the effect of FH of AD on associated psychopathology, and not in current diagnosis per se. Therefore, we pooled a selected sample of depressed / anxious patients, since a FH of AD predisposes to both depression and anxiety disorders. Moreover, splitting FH groups based on current diagnosis would result in groups too small for valid analysis. Finally, such a strategy would only account for the current status of psychopathology, whereas a substantial subgroup of the patients with current 'pure' depression or anxiety had met diagnostic criteria for the other psychopathology type at some point during their lifetime. Separating patient groups based on current psychopathology would therefore still give relatively heterogeneous groups.
According to the mean scores on severity questionnaires like the MADRS and IDS, severity of current psychopathology was mild to moderate only, so that a potential dose-response association may have been missed.
Results were unaffected by SSRI use, confirming earlier reports within the NESDA-Neuroimaging study that also failed to observe effects of SSRIs on fMRI-parameters (van Tol et al. 2011; van Tol et al. 2012) . It should however be noted that current findings are based on cross-sectional analyses; thus the possibility of within-subject changes in BOLD responses as an effect of SSRI use cannot be fully excluded.
Another potential limitation is the indirect assessment of familial AD, since NESDA did not directly interview first-degree relatives. Using the family-tree method, relying on participants' self-reported data of FH is likely to lead to under-reporting of familial AD. However, this would, if anything, have resulted in an underestimation of the true effects of familial AD.
Importantly, none of the participants in the current study had a lifetime diagnosis of AD and the groups did not differ in alcohol use, or the presence of alcohol use symptoms according to the AUDIT, ruling out the possibility that observed effects are due to the neurotoxic effects of alcohol use.
Together, the results in this study demonstrate that a FH of AD influences the neurophysiological profile of mood / anxiety disorders through adverse effects on cognitive functions, possibly decreasing the ability to regulate emotional states and increasing the risk of sustained negative symptoms seen in mood / anxiety disorders. On the other side, the presence of a FH of AD may have a protective effect on decreased positive emotional appraisal in patients with mood / anxiety disorders. The current neurophysiological findings may be associated with previous findings that a FH of AD is associated with less dysphoric mood induction in healthy controls after ketamine administration (Petrakis et al. 2004 ) and with better treatment effects in treatment-resistant patients with a major depression (Phelps et al. 2009 ). Therefore, results of the present study may contribute to a better characterization of the heterogeneity within the group of patients with a mood / anxiety disorder (Wardenaar et al. 2011) , to a better understanding of heterogeneous reactions of patients with mood / anxiety disorders to pharmacological interventions (Phelps et al. 2009) , to an effective profiling of patients, and finally to the development of personalized medicine in the treatment of mood and anxiety disorders (Bartova et al. 2010; Uher 2011) .
SUPPLEMENTARY MATERIAL
In-and Exclusion criteria for the NESDA-Neuroimaging study
Participants were drawn from the Netherlands Study of Depression and Anxiety (NESDA), a large cohort study (Penninx et al. 2008) . Out of the 2981 NESDA participants (main sample, baseline measurement), a subset of patients and healthy controls (HCs) aged 18 to 57 years, was selected for magnetic resonance imaging (MRI) scanning during the NESDA-neuroimaging study. Inclusion Figure S3 .3 -Flow diagram; inclusion/exclusion from the NESDA-neuroimaging study. After scanning, we excluded participants that did not meet the criteria defined for the current study (non-alcoholic FH+ / FH-), and who had poor task and/or imaging data. Of the original 233 patients, finally 77 met all criteria for the FH-group and 31 for the FH+ group. Of the original 68 healthy controls (HC), finally 31 served as post hoc comparison group without a family history of alcohol dependence. Of note, we excluded patients with bad structural imaging data, to start with the same sample as described in Sjoerds et al. (2012). criteria for patients in the NESDA-neuroimaging study were current major depressive disorder (MDD) and/or anxiety disorder (panic disorder; and/or social anxiety disorder; and/or generalized anxiety disorder) in the past 6 months according to DSM-IV-TR criteria. Diagnoses were established using the structured Composite International Diagnostic Interview (CIDI; WHO lifetime version 2.1) (Robins et al. 1988 ) administered by a trained interviewer.
Exclusion criteria for the patient group were the presence of Axis-I disorders other than MDD or the abovementioned anxiety disorders; any use of psychotropic medication other than a stable use of selective serotonin reuptake inhibitors (SSRIs) or infrequent benzodiazepine use (three times two tablets weekly or within 48 hours before scanning). Exclusion criteria for both patients and HCs were the presence or history of major internal or neurological disorder; dependency or recent abuse (past year) of alcohol or drugs; hypertension (>180/130 mmHg); heavy smoking (>5 cigarettes per day); and general MRI contraindications. The HCs had no lifetime depressive or anxiety disorders, no lifetime alcohol or drug use disorder and were not taking any psychotropic drugs. In total, 301 native Dutch-speaking participants (233 patients and 68 HCs) were included and underwent MR imaging at one of the three participating centers, i.e., Leiden University Medical Center (LUMC), Amsterdam Medical Center (AMC), and University Medical Center Groningen (UMCG). For more information on the exact number of patients included/excluded for various reasons, the reader is referred to the flowchart in figure S3.3.
Detailed task description
The emotional word memory (EWM) task and the Tower of London (ToL) task were administered as part of a larger functional and structural imaging study (van Tol et al. 2011; van Tol et al. 2012) . The ToL task was administered first and the EWM task as the second task for all participants. Participants' responses and response times were registered by two magnet-compatible button boxes. No feedback regarding the response was provided.
Tower of London Task
We used an event-related parametric version of the ToL task (van den Heuvel et al. 2003) , which consisted of a planning and a baseline condition ( figure S3.4) . In the planning condition, participants were presented a starting configuration and a target configuration. In both configurations, three colored beads were placed on three vertical rods, which could accommodate one, two, or three beads, respectively. One bead could be moved at a time and only when there was no other bead on top. Participants were requested to determine the minimum number of steps (ranging from 1 to 5) needed to reach the target configuration by mentally moving beads one at a time. Two possible answers were shown. Subjects had to press the button corresponding to the side (left or right) of the screen where the correct answer was presented. In the baseline condition, subjects were instructed to count the total number of yellow and blue beads, a task that does not require any planning activity. The display was similar to the planning condition, but the number of beads of each color in the two configurations, used for the baseline condition, was unequal, with the aim of preventing planning activity. We used a pseudo-randomized, self-paced design with maximal response duration of 60 seconds for each trial, presented using E-prime (Psychological Software Tools, Pittsburgh, PA, USA). We adopted a pseudo-randomized design to control for any overflow effects (i.e., persevering of task-related cognitive processes after a difficult trial). Therefore, each trial of three or more moves was followed by a baseline trial. Before the scanning session, subjects received instructions and a standardized training of 10 items, two at each level of difficulty in which errors were corrected. All subjects understood the task rules and instructions.
Emotional Word Memory Task
The EWM task used an event-related, self-paced, implicit word encoding-and recognition paradigm (Daselaar et al. 2003 ) (figure S3.5). During the encoding part, 40 positive, 40 negative and 40 neutral words, and 40 baseline trials were presented in 20 blocks of eight words. Words were presented with an average inter-stimulus interval of 1026 ms (minimum, 1018 ms; maximum, 1035 ms). Within each block, two negative words, two positive words, two neutral words and two baseline trials were presented in randomized order. Across valence (i.e., positive, negative, neutral), words were matched for length (ranging from three to twelve letters) and frequency of occurrence in the Dutch language. The task was paced by the subject, but each word was presented with a maximal duration of 5 seconds. During each stimulus presentation, response options were displayed at the bottom of the screen. Subjects had to indicate whether they thought the word presented was positive, negative, or neutral to them. Baseline words were '<<left', '<<middle>>', and 'right>>' and participants were instructed to press the corresponding button. To protect against primacy and recency effects three filler (1 positive, 1 negative, 1 neutral) words were presented at the start and end of the encoding task. These filler words were not part of the subsequent recognition task. The recognition test phase consisted of the 120 old encoding target words and 120 new distracter words, and 40 baseline trials. Again, words were presented in a pseudo-randomized order in 20 blocks of 14 words, each block containing two old and two new negative words, two old and two new positive words, two old and two new neutral words, and two baseline trials. 'Old' and 'new' words were matched on complexity, word length, and emotional intensity. Subjects had to indicate whether they 'have seen' (i.e., remembered) the words previously, 'probably have seen it' (i.e., know), or 'haven't seen it' (rejection). The interval between the encoding and recognition task was 10 minutes. In the retention interval, a neutral image was displayed, to minimize interference effects during the subsequent recognition phase. During the retention interval, the structural image was acquired.
Figure S3.4 -The Tower of London task (ToL).
A parametric executive functioning test consisting of planning trials, where participants had to compute the minimal number of steps (ranging from 1 to 5) to reach the target situation (left figure) , and baseline trials with no planning involved, where participants had to count the yellow and blue balls (right figure).
Figure S3.5 -The Emotional Word Memory task (EWM).
A memory task consisting of an encoding phase, where participants had to indicate whether the word had a positive, negative or neutral valence (left set of words, 40 words per valence and 40 baseline trials), and a recognition phase where participants had to indicate whether they had seen the word during the encoding phase or not (right set of words, 40 old words plus 40 distracter words per valence and 40 baseline trials). 
